Selventa Strengthens Intellectual Property for SysDx™ Approach to Personalized Medicine

News   May 09, 2013

 
Selventa Strengthens Intellectual Property for SysDx™ Approach to Personalized Medicine
 
 
 

RELATED ARTICLES

Bile Acids Turn Cells from Fat-storing to Fat-burning

News

EPFL scientists have discovered a novel role for bile acids: converting energy-storing white fat depots into energy-expending beige fat.

READ MORE

The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

News

The Salk Institute and Indivumed GmbH, a world leading cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting-edge basic and translational research in cancer.

READ MORE

Can Epigenetics Help Explain the Mechanisms of Autism?

News

New findings suggest that epigenetic analysis of DNA regions that control gene expression may hold clues to the genetic basis of autism spectrum disorder.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE